Passive

Invesco Dorsey Wright Healthcare Momentum ETF

The Invesco Dorsey Wright Healthcare Momentum ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical LeadersTM Index (the “Underlying Index”).

$43.78

+17.6% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Dorsey Wright Healthcare Momentum ETF PTH
Fund Size
$151 Million
Dividend
0.0%
Fees
0.60%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.6%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$361 Billion
Dividend
3.2%
Fees
0.07%
View 1286 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $19.8 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.07 %
Beta Indicates the relationship between the price performance of a share and the market. 0.8823
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 73.02
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -19.5
Profitable Companies 41
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 407.28
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.37
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company -0.67
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 26.0
Enterprise Value to Revenue Enterprise value divided by revenue 25.93
Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -3.7312
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -90.53%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 24.20%
Return on Assets Indicates a company's profitability in relation to its total assets. -1.25%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -2.37%

Industries

Healthcare 82.9%
Other 5.7%
N/A 11.4%

Market cap

Micro Cap 11%
Small Cap 22%
Mid Cap 43%
Large Cap 20%
Mega Cap 4%

35 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$25.8 Million
Weight
22.6%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$10.5 Million
Weight
9.2%
Medpace Holdings, Inc. logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings, Inc.

P/E-Ratio
45.0
Total Investment
$5.39 Million
Weight
4.7%
Eli Lilly and Co. logo

LLY - Manufacturing

Eli Lilly and Co.

P/E-Ratio
139.7
Total Investment
$5.33 Million
Weight
4.7%
CymaBay Therapeutics, Inc. logo

CBAY - Manufacturing

CymaBay Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$4.95 Million
Weight
4.3%
BridgeBio Pharma, Inc. logo

BBIO - Manufacturing

BridgeBio Pharma, Inc.

P/E-Ratio
-7.9
Total Investment
$4.82 Million
Weight
4.2%
Ardelyx, Inc. logo

ARDX - Manufacturing

Ardelyx, Inc.

P/E-Ratio
0.0
Total Investment
$4.4 Million
Weight
3.8%
IDEXX Laboratories, Inc. logo

IDXX - Manufacturing

IDEXX Laboratories, Inc.

P/E-Ratio
52.3
Total Investment
$4.31 Million
Weight
3.8%
IDEAYA Biosciences, Inc. logo

IDYA - Professional, Scientific, and Technical Services

IDEAYA Biosciences, Inc.

P/E-Ratio
-30.1
Total Investment
$4.24 Million
Weight
3.7%
MoonLake Immunotherapeutics logo

MLTX

MoonLake Immunotherapeutics

P/E-Ratio
0.0
Total Investment
$4.17 Million
Weight
3.6%
Stryker Corp. logo

SYK - Manufacturing

Stryker Corp.

P/E-Ratio
42.4
Total Investment
$3.98 Million
Weight
3.5%
HCA Healthcare, Inc. logo

HCA - Health Care and Social Assistance

HCA Healthcare, Inc.

P/E-Ratio
16.6
Total Investment
$3.96 Million
Weight
3.5%
Nuvalent, Inc. logo

NUVL - Professional, Scientific, and Technical Services

Nuvalent, Inc.

P/E-Ratio
0.0
Total Investment
$3.93 Million
Weight
3.4%
Crinetics Pharmaceuticals, Inc. logo

CRNX - Professional, Scientific, and Technical Services

Crinetics Pharmaceuticals, Inc.

P/E-Ratio
-14.6
Total Investment
$3.82 Million
Weight
3.3%
Roivant Sciences Ltd. logo

ROIV

Roivant Sciences Ltd.

P/E-Ratio
1.8
Total Investment
$3.76 Million
Weight
3.3%
RadNet, Inc. logo

RDNT - Manufacturing

RadNet, Inc.

P/E-Ratio
1061.1
Total Investment
$3.63 Million
Weight
3.2%
Tango Therapeutics, Inc. logo

TNGX - Professional, Scientific, and Technical Services

Tango Therapeutics, Inc.

P/E-Ratio
-8.1
Total Investment
$3.58 Million
Weight
3.1%
Haemonetics Corp. logo

HAE - Manufacturing

Haemonetics Corp.

P/E-Ratio
32.2
Total Investment
$3.57 Million
Weight
3.1%
CorVel Corp. logo

CorVel Corp.

P/E-Ratio
n/a
Total Investment
$3.57 Million
Weight
3.1%
Glaukos Corp. logo

GKOS - Manufacturing

Glaukos Corp.

P/E-Ratio
-32.2
Total Investment
$3.48 Million
Weight
3.0%
ANI Pharmaceuticals, Inc. logo

ANIP - Manufacturing

ANI Pharmaceuticals, Inc.

P/E-Ratio
85.3
Total Investment
$3.46 Million
Weight
3.0%
Disc Medicine, Inc. logo

IRON - Manufacturing

Disc Medicine, Inc.

P/E-Ratio
0.0
Total Investment
$3.43 Million
Weight
3.0%
Cabaletta Bio, Inc. logo

CABA - Professional, Scientific, and Technical Services

Cabaletta Bio, Inc.

P/E-Ratio
0.0
Total Investment
$3.35 Million
Weight
2.9%
Mirum Pharmaceuticals, Inc. logo

MIRM - Professional, Scientific, and Technical Services

Mirum Pharmaceuticals, Inc.

P/E-Ratio
-7.5
Total Investment
$3.33 Million
Weight
2.9%
Corcept Therapeutics Inc. logo

CORT - Manufacturing

Corcept Therapeutics Inc.

P/E-Ratio
24.1
Total Investment
$3.25 Million
Weight
2.8%